Trial Design Solutions
-
Recruit Patients Faster In The Asia-Pacific Region
9/29/2022
Novotech relies on years of experience, in-country knowledge and real-life big data to identify and propose the best-performing sites and investigators for your study.
-
Faster, Simpler Trial Management
7/20/2023
Explore how Rave CTMS intelligently connects various workflows, facilitates data-driven insights, and promotes collaboration among stakeholders, all while harnessing the power of unified data capture.
-
Deliver Personalized Participant Logistics And Concierge Services
4/15/2024
Our comprehensive service eliminates the burden on sites and patients to handle travel and lodging arrangements while guaranteeing upfront coverage of all expenses.
-
End-To-End Ophthalmic Drug Development Solutions
4/9/2024
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions support programs from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
-
A Clinical Command Center For Efficient, Compliant Research
9/11/2023
Streamline research operations globally within Longboat for all sites, sponsors, CROs, and patients to expedite study start-up, facilitate efficient and compliant study management, elevate patient outcomes, and enhance vital coordination efforts.
-
Advarra University And Training
1/17/2023
Advarra University is the main hub for all of the training opportunities to help your team and staff feel confident in navigating the technology in their day-to-day operations.
-
First In Human (FIH) Fact Sheet
1/26/2023
Altasciences has decades of experience designing, conducting, and reporting on first-in-human (FIH) clinical trials. For small or large molecules, simple or complex trials, we have the expertise, purpose-built Phase 1 facilities, and seamless processes to deliver quality with speed and ease.
-
Clinical And Regulatory Strategy
11/7/2023
Many biotechnology companies come to Australia to conduct early phase clinical trials and take advantage of straightforward regulatory streams and of the lucrative 43.5% R&D cash refund scheme. Biotechnology companies then often look at locations in Asia, such as South Korea, Thailand and China to tap into their huge treatment-naïve patient populations for their later phase clinical research.
-
NextGen Participant Engagement Platform
11/16/2023
Uncover how the GreenSpace platform can address delays in trial timelines by overcoming insufficient recruitment and retention efforts.
-
GMO Solutions
6/27/2023
Novotech initiated the first national, privately owned, commercial Institutional Biosafety Committee (IBC) in Australia, successfully accredited by the Australian Office of the Gene Technology Regulator (OGTR).